Super-enhancer acquisition drives oncogene expression in triple negative breast cancer
Super-enhancer acquisition drives oncogene expression in triple negative breast cancer
About this item
Full title
Author / Creator
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Triple Negative Breast Cancer (TNBC) is a heterogeneous disease lacking known molecular drivers and effective targeted therapies. Cytotoxic chemotherapy remains the mainstay of treatment for TNBCs, which have significantly poorer survival rates compared to other breast cancer subtypes. In addition to changes within the coding genome, aberrant enhan...
Alternative Titles
Full title
Super-enhancer acquisition drives oncogene expression in triple negative breast cancer
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2417365784
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2417365784
Other Identifiers
ISSN
1932-6203
E-ISSN
1932-6203
DOI
10.1371/journal.pone.0235343
